Anabio R&D

slider-home-1903×640

For The Future

Without Antibiotics

We are together

slider-home-02

Assume Responsibility For

A Highest Quality Products

We commit to observe the modern technologies and advanced research equipment to

Home 1

ABOUT US

We are together For The Future Without Antibiotics

From the fact that “Antibiotic resistance – The pain of humanity”, ANABIO R&D is constantly striving to find, research and develop the new products that apply Spore Probiotic Technology to protect and improve human health comprehensively, naturally and effectively.

Commits to use the modern technologies
Commits to use advanced research equipment
Ensure products are created with the best quality
Desire to take care of health for every person in a safe and sustainable way

Call for any questions

0242 2253211

sign-02

Dr. Nguyen Hoa Anh,

Director ANABIO R&D

Spobio Center

Spobiotic Research Center (Spobio Center)

The Spobiotic Research Center is equipped with many modern machines and equipment for in-depth researches on spore probiotics using techniques of microbiology, biophysics, biochemistry, molecullar and cellular biology

About Us

Overall Introduction

Spobiotic Research Center (Spobio Center) was established on May 18th, 2022. Spobio Center comes out into society with the aim of building an in-depth research center on spore probiotics and will be the driving force for more scientists around the world to be interested in and develop spore probiotics as a possible solution for a future without antibiotics

09 +

International publications

15 +

National publications

12 +

Conference reports

05 +

Patent registration

08 ₊

Trademark registration

What we do

The Prominent Studies

We are aware that product is the foundation of business. We make efforts ceaselessly in research and development of products that apply spore probiotics technology to protect anf improve human health comprehensively

Study on application of LiveSpo® Navax in the supportive treatment of acute rhinosinusitis and chronic purulent otitis media

Assessment of acute and sub-acute toxicity of two products for gastrointestinal tract LiveSpo® COLON (an other name LiveSpo® Colytis) and LiveSpo® OVAX (an other name LiveSpo® Ovax Kids)

Blind, randomized and controlled clinical trial for evaluation of safety and efficacy of LiveSpo® COLON in supportive treatment of colitis in combination with the routine treatment regimen

Assessment of acute and sub-acute toxicity in oral administration, eyes irritation test, nose irritation test and mucosa irritation test of LiveSpo® NAVAX

Study on application of LiveSpo® Navax in treatment of Acute Respiratory Tract Infections due to RSV (Respiratory syncytial virus) and influenza virus

OUR NEWS

Recent Articles And News

admin November 18, 2025November 18, 2025

Updates from the 2025 National Gastroenterology Conference: Emerging Disease Trends and Clinical Evidence on the Role of the Probiotic LiveSpo®COLON

The 31st Annual National Gastroenterology Scientific Conference (2025), held in Ninh Binh from October 31 to N...

admin November 17, 2025November 17, 2025

LiveSpo Dia30 and LiveSpo Navax Multi-Strain Bacillus Spore Formulations for Digestive and Respiratory Health Presented at Pharmacity’s Annual Conference

At the Pharmacity Annual Conference held in Ho Chi Minh City on November 14, 2025, Assoc. Prof. Dr. Nguyen Thi...

admin November 17, 2025November 17, 2025

ANABIO R&D’s Spobiotic Research Center Presents LiveSpo Navax at IDWeek 2025: International Scientific Exchange on Infectious Diseases

At IDWeek 2025, held in Atlanta, Georgia, USA, from October 19-22, 2025, Dr. Nguyen Hoa Anh representing LiveS...

admin May 22, 2025May 22, 2025

KỶ NIỆM 3 NĂM THÀNH LẬP TRUNG TÂM NGHIÊN CỨU BÀO TỬ LỢI KHUẨN(18/05/2022 – 18/05/2025)

Ngày 18/05/2025 đánh dấu cột mốc 3 năm hình thành và phát triển của Trung tâm Nghiên cứu...

RESEARCH COOPERATION

Cooperation Units

Hosted By Wordpress Clusters